The future of science and technology is in China, not US. 科學技術的未來在中國，不在美國.
49歲的中國幹細胞研究專家吳軍在美國學習、工作20多年，今年剛剛晉升為美國德克薩斯大學西南醫學中心終身正教授，但他決定放棄$500,000美元年薪的高薪職位，今年9月返回中國正式全職加盟杭州西湖大學，擔任幹細胞生物學和再生醫學講席教授. 值得注意的是，《南華早報》2026年10月15日報道，吳軍教授表示，美國原僱主曾考慮提出更好的待遇挽留他，但他已決定回國，金錢無法改變其決定.
原單位得知吳軍打算離開後，曾誠懇挽留，甚至考慮提出新的待遇方案，但吳軍最終婉拒。吳軍接受《南華早報》訪問時說：「我早已決定回中國，再多的錢也留不住我。」
https://weixin.qq.com/sph/AV9ksodBZo
https://www.tt.site/t/ZPLAR7hrD/
1977年出生於山東的吳軍，本科畢業於山東大學醫學院。2003年，他赴美國田納西大學攻讀生命科學博士學位，此後先後在南加州大學和索爾克生物研究所從事博士後研究。
2018年，吳軍加入美國德克薩斯大學西南醫學中心分子生物學系，擔任助理教授。憑藉在幹細胞生物學、胚胎發育和跨物種嵌合體研究方面取得的成果，他於2023年晉升副教授，並在2026年晉升正教授。
吳軍透露，促使他下定決心的重要因素之一，是中國在相關領域不斷集聚的科研人才，「包括我們實驗室和其他實驗室培養出來的人。」在吳軍看來，中國相關領域不斷集聚的科研人才、持續改善的研究環境，以及培養下一代青年科學家的機會，已經足以讓他作出新的選擇。他認為，中國對前沿生命科學研究的重視，以及相對有利於人體胚胎模型研究的科研環境，同樣是促使自己作出回國決定的重要原因。
The 49-year-old Chinese stem cell research expert Wu Jun studied and worked in the US for more than 20 years and this year was just promoted to tenured full professor at the University of Texas Southwestern Medical Center in the US, but he decided to give up a high-paying position with an annual salary of $500,000 and return to China in September this year to formally join Westlake University in Hangzhou full-time as a chair professor of stem cell biology and regenerative medicine. It is worth noting that the South China Morning Post reported on October 15, 2026, that Professor Wu Jun said his former U.S. employer had considered offering him better terms to retain him, but he had already decided to return to China, and money could not change his decision.
After learning that Wu Jun intended to leave, his original work unit sincerely tried to retain him and even considered proposing a new compensation package, but Wu Jun ultimately declined. In an interview with the South China Morning Post, Wu Jun said: “I had long decided to return to China; no amount of money could keep me here.”
Wu Jun was born in Shandong in 1977 and completed his undergraduate studies at the School of Medicine of Shandong University. In 2003, he went to the University of Tennessee in the United States to pursue a doctoral degree in life sciences, and afterward conducted postdoctoral research at the University of Southern California and the Salk Institute for Biological Studies.
In 2018, Wu Jun joined the Department of Molecular Biology at the University of Texas Southwestern Medical Center in the United States as an assistant professor. On the strength of his achievements in stem cell biology, embryonic development, and cross-species chimera research, he was promoted to associate professor in 2023 and to full professor in 2026.
Wu Jun revealed that one of the important factors that prompted him to make up his mind was the growing concentration of scientific research talent in related fields in China, “including people trained in our laboratory and other laboratories.” In Wu Jun’s view, the growing concentration of scientific research talent in related fields in China, the continuously improving research environment, and the opportunity to train the next generation of young scientists were already enough for him to make a new choice. He believes that China’s emphasis on cutting-edge life science research, as well as a research environment relatively favorable to human embryo model research, were also important reasons that prompted him to make the decision to return to China.
